## AMBA: Ambarella, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -3.0% below STRENGTH zone (3.0-6.0%); PEG 4.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($64.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Insider Sell: Elizabeth Schwarting Sells Shares of Ambarella Inc (AMBA)**
- Source: GuruFocus | 20251219T000907 | Somewhat-Bearish | Relevance: 100%
- Elizabeth Schwarting, a Director at Ambarella Inc (AMBA), sold 624 shares on December 16, 2025, reducing her total holdings to 6,690 shares. This transaction follows a pattern of 35 insider sells and no insider buys for AMBA over the past year. Ambarella stock, valued at $72.38 on the day of sale, is considered modestly undervalued with a GF Value of $80.30.

**2. Insider Selling: Ambarella (NASDAQ:AMBA) Director Sells 624 Shares of Stock**
- Source: MarketBeat | 20251218T230907 | Neutral | Relevance: 100%
- Ambarella Director Elizabeth Schwarting sold 624 shares of AMBA stock on December 16th, reducing her stake by 8.53%. Despite the insider selling, Ambarella recently beat quarterly EPS estimates and saw significant institutional accumulation from major funds. Analysts currently rate Ambarella as a "Moderate Buy" with an average price target of $96.00.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | B of A Securiti | $92 | $90 | +2% |
| 2025-11-26 | Rosenblatt | $115 | $100 | +15% |
| 2025-11-26 | Stifel | $100 | $90 | +11% |
| 2025-11-26 | Needham | $100 | $100 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | B of A Securiti | main | Neutral |
| 2025-11-26 | Rosenblatt | main | Buy |
| 2025-11-26 | Stifel | reit | Buy |
| 2025-11-26 | Needham | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 4 ($1.18M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (+0.1%)
- Blackrock Inc.: 9.1% (+0.1%)
- State Street Corpora: 3.9% (-9.4%)
- Jericho Capital Asse: 2.8% (+10.5%)
- Fuller & Thaler Asse: 2.6% (+8.9%)

### Key Risks

1. High beta (1.98) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_10 falling (-3.4% 5d) with bearish MACD, trend may be turning.
3. Valuation stretched: PEG 5.0x requires aggressive growth execution.
4. Near-term weakness: 11.2% below SMA50 despite long-term uptrend.

### Catalysts

- Analyst target momentum: 3 raises (avg +9%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.96 signals overvaluation risk, limited margin of safety. Forward P/E 117.3x stretched relative to 4% growth. Balance sheet: strong liquidity (2.7x), low leverage (D/E 0.27). Analyst sentiment positive (3 raises, avg +9%). Insider selling cluster ($1.2M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $3.1B |
| Beta | 1.98 |
| 52W Range | $38.86 - $96.69 |
| Short Interest | 7.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.96 |
| Forward P/E | 117.3 |
| Current P/E | 121.8 |
| YoY Growth | 3.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 0.3% to -3.0% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.0pp (needs >3.0% for momentum thesis). Underperforming sector by 3.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). RSI neutral at 42. OFD pattern: +F0N (Breakout).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.04% (CS: 13) | Weak |
| RSI_14 | 41.8 | Neutral |
| MACD Histogram | -0.26 | Bearish |
| vs SMA20 | 0.955x | Below |
| vs SMA50 | 0.888x | Below |
| vs SMA200 | 1.073x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $72.52
- **Stop Loss:** $64.16 (11.5% risk)
- **Target:** $80.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 143
- **Position Value:** $10,370.36
- **Portfolio %:** 10.37%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-25 (Est: $0.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.21 | $0.27 | +29.6% |
| 2025Q3 | $0.05 | $0.15 | +177.1% |
| 2025Q2 | $0.04 | $0.07 | +83.1% |
| 2025Q1 | $-0.02 | $0.11 | +651.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*